Fully funded place including home (UK) tuition fees and a tax-free stipend in the region of £17,009. Students from the EU are welcome to submit an application for funding, any offers will be subject to BBSRC approval and criteria.
1. Mercer PF, … & Chambers RC . Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. Thorax 2016; 71.
2. Lukey P, … Chambers RC,… Maher TM. A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis. Eur Respir J. 2019; 53.
3. Woodcock, H.V., .. & Chambers RC., The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
Nat Commun. 2019; 10.
4. mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β1-induced collagen biosynthesis. Selvarajah B, … & Chambers RC. Sci Signal. 2019 May 21;1